Philippe Pourquery will join SGD Pharma, global leader in glass pharmaceutical packaging, from May 6, 2024 as Group Financial Officer and member of the Executive Committee, in replacement of Jérôme Brassens. Philippe will be responsible for Finance and IT across the Group.
At the end of January, SGD Pharma, a global leader in glass primary packaging for the pharmaceutical industry, started a two-week trial using 100% hydrogen burners for industrial-scale glass production. The trial, conducted at SGD Pharma’s state-of-the-art Saint-Quentin-Lamotte (SQLM) manufacturing plant in France, was a resounding success and will inform SGD Pharma’s decarbonization roadmap which aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040.
SGD Pharma, a global leader in glass pharmaceutical packaging, has achieved a gold medal in EcoVadis’ 2024 sustainability ratings. Building upon previous years, SGD Pharma’s score of 78 puts the business in the 98th percentile for manufacturers of glass and glass products.
SGD Pharma has launched a new range of innovative Type I tubular vials for injectable drugs with an external low coefficient of friction (COF) coating developed by Corning, to help manufacturers optimize their fill and finish operations. Disruptions on pharmaceutical filling lines may be caused by tip-overs, jams and glass breakages, all due to frictional resistance from glass-to-glass and glass-to-metal contact. Damage and disruption to the flow of vials may result in recalls and increased manufacturing costs.
